NOAEL Studies
Cosmetic Ingredient
Basic Brown 16 NOAEL Studies
INCI: BASIC BROWN 16
CAS: 26381-41-9
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 150 | mg/kg bw/day | rat | oral | 13 week | Subchronic | SCCS; Potokar, M., et al. (1985) Arianor Mahogany. 90-Tage-Test nach wiederholter oralerVerabreichung an Ratten. Institut für Toxikologie, Henkel KGaA, Düsseldorf, Germany.Archive code at Henkel KGaA, Düsseldorf: TBD 850004 |
| COSMOS DB | NOAEL | 50 | mg/kg bw/day | rat | oral | 13 week | Subchronic | SCCS; Potokar, M., et al. (1985) Arianor Mahogany. 90-Tage-Test nach wiederholter oralerVerabreichung an Ratten. Institut für Toxikologie, Henkel KGaA, Düsseldorf, Germany.Archive code at Henkel KGaA, Düsseldorf: TBD 850004 |
SCCNFP Opinion 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =50 | mg/kg | rabbit | dermal | Sub-chronic | repeated dose toxicity | Ref. : 7 2, p.7 |
| SCCNFP Opinion | NOAEL | >94 | % | human | dermal | - | dermal absorption | Ref. : 12 2, p.13 |
SCCS Opinion 20 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =50 | % | - | - | 90-day | NOAEL study | Ref: 1 Comment The Purity by NMR = 65, p.8 |
| SCCS Opinion | NOAEL | =65.7 | % | - | - | Chronic | genotoxicity | p.16 |
| SCCS Opinion | NOAEL | =90 | mg/kg | rat | - | - | developmental toxicity | p.21 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw/day | rat | oral | 90-day | carcinogenicity | p.22 |
| SCCS Opinion | NOAEL | =33 | mg/kg bw/day | rat | oral | 90-day | NOAEL study | p.22 |
| SCCS Opinion | NOAEL | =8 | - | - | - | 90-day | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =3.1 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =7 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =0.5 | % | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =1.2 | % | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =6024 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =89.1 | % | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =100 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =10 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =1.66 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =169 | - | - | - | - | NOAEL study | p.8 |
| SCCS Opinion | NOAEL | =90 | mg/kg bw/day | rat | - | - | reproductive toxicity | p.24 |
| SCCS Opinion | NOAEL | =0.095 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.25 |
| SCCS Opinion | NOAEL | =33 | mg/kg bw/d | - | oral | - | irritation | p.26 |
| SCCS Opinion | NOAEL | =59 | mg/kg bw/d | - | oral | - | irritation | p.26 |
Regulatory source 21 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | dermal absorption | >94 | % | human | dermal | - | dermal absorption | p.13 |
| Regulatory source | repeated dose toxicity | 50 | mg/kg | rabbit | dermal | Sub-chronic | repeated dose toxicity | p.7 |
| Regulatory source | - | 50 | % | - | - | 90-day | - | p.8 |
| Regulatory source | - | 65.7 | % | human | - | - | - | p.22 |
| Regulatory source | - | 33 | mg/kg bw/day | rat | oral | 90-day | - | p.22 |
| Regulatory source | - | 8 | - | - | - | 90-day | - | p.8 |
| Regulatory source | - | 3.1 | - | - | - | - | - | p.8 |
| Regulatory source | - | 7 | - | - | - | - | - | p.8 |
| Regulatory source | - | 0.5 | % | - | - | - | - | p.8 |
| Regulatory source | - | 1.2 | % | - | - | - | - | p.8 |
| Regulatory source | - | 6024 | - | - | - | - | - | p.8 |
| Regulatory source | - | =89.1 | % | - | - | - | - | p.8 |
| Regulatory source | - | =50 | % | - | - | - | - | p.8 |
| Regulatory source | - | >100 | - | - | - | - | - | p.8 |
| Regulatory source | - | 10 | - | - | - | - | - | p.8 |
| Regulatory source | - | 50 | - | - | - | - | - | p.8 |
| Regulatory source | - | 1.66 | - | - | - | - | - | p.8 |
| Regulatory source | - | 169 | - | - | - | - | - | p.8 |
| Regulatory source | carcinogenicity | 50 | mg/kg bw/day | rat | oral | 90-day | carcinogenicity | p.22 |
| Regulatory source | developmental toxicity | 90 | mg/kg | rat | - | - | developmental toxicity | p.21 |
| Regulatory source | genotoxicity | 65.7 | % | - | - | Chronic | genotoxicity | p.16 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | QEJ5GK0TG1 | UNII | - | - | - | chemical | - |